Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients

Basit Öğe Kaydı
dc.contributor.authorEcevit, C. O.
dc.contributor.authorAktas, S.
dc.contributor.authorYildirim, H. T.
dc.contributor.authorDemirag, B.
dc.contributor.authorErbay, A.
dc.contributor.authorKaraca, I.
dc.contributor.authorCelik, A.
dc.contributor.authorDemir, B.
dc.contributor.authorErcetin, P.
dc.contributor.authorOlgun, N.
dc.date.accessioned2019-10-27T11:24:46Z
dc.date.available2019-10-27T11:24:46Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS237en_US
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.startpageS237en_US
dc.identifier.urihttps://hdl.handle.net/11454/33317
dc.identifier.volume63en_US
dc.identifier.wosWOS:000384818801416en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofPediatric Blood & Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleOncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patientsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu